Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Sortierreihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (18) Birchmeier, Walter Prof. Dr. (23) Birchmeier-Kohler, Carmen Prof. Dr. (10) Dechend, Ralf Priv. Doz. (5) Falcke, Martin Prof. Dr. (1) Hübner, Norbert Prof. Dr. (8) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Jentsch, Thomas Prof. Dr. (20) Kettenmann, Helmut Prof. Dr. (28) Kettritz, Ralph Prof. Dr. (4) Klußmann, Enno PD Dr. (1) Kühn, Ralf Dr. (10) Leutz, Achim Prof. Dr. (7) Lewin, Gary Prof. Dr. (5) Luft, Friedrich Prof. Dr. (54) Morano, Ingo Prof. Dr. (10) Niendorf, Thoralf Prof. Dr. (5) Rajewsky, Klaus Prof. Dr. (7) Rajewsky, Nikolaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (2) Schmitz, Dietmar Prof. Dr. (6) Schulz-Menger, Jeanette Prof. Dr. (1) Spuler, Simone Prof. (3) Wanker, Erich Prof. Dr. (4) (-) Blankenstein, Thomas Prof. Dr. (13) (-) Müller, Dominik Prof. Dr. (1) Genetik und Pathophysiologie des Herz - Kreislaufsystems (1) Hypertonie-vermittelter Endorganschaden (1) Hypertonie bedingte Endorganschäden (1) Molekulare Immunologie und Gentherapie (13) 1992 (4) 1993 (7) (-) 1994 (5) (-) 1995 (9) 1996 (6) 1997 (10) 1998 (12) 1999 (5) 2001 (16) 2002 (13) 2005 (20) 2006 (5) 2007 (17) 2008 (22) 2009 (15) 2010 (21) 2011 (18) 2012 (16) 2013 (24) 2015 (13) 2016 (15) 2017 (17) 2018 (15) 2019 (22) 2020 (16) 14 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Müller, Dominik Prof. Dr.19941995 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1995 in Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein 01. Januar 1995 in J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling 01. Januar 1995 in Hypertension Effects of human renin in the vasculature of rats transgenic for human angiotensinogen D.N. Mueller K.F. Hilgers J. Bohlender A. Lippoldt J. Wagner W. Fischli D. Ganten J.F.E. Mann F.C. Luft 01. Januar 1995 in Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein 01. Januar 1995 in Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu 01. Januar 1995 in Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein 01. Januar 1995 in Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein 01. Januar 1995 in Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein 01. Januar 1995 in Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu 01. Januar 1994 in Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 1995 in Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
01. Januar 1995 in J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
01. Januar 1995 in Hypertension Effects of human renin in the vasculature of rats transgenic for human angiotensinogen D.N. Mueller K.F. Hilgers J. Bohlender A. Lippoldt J. Wagner W. Fischli D. Ganten J.F.E. Mann F.C. Luft
01. Januar 1995 in Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein
01. Januar 1995 in Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu
01. Januar 1995 in Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein
01. Januar 1995 in Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein
01. Januar 1995 in Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein
01. Januar 1995 in Canc Gene Ther Vectors in cancer therapy: how will they deliver M. Blaese T. Blankenstein M. Brenner O. Cohen-Haguenauer B. Gansbacher S. Russell B. Sorrentino T. Velu
01. Januar 1994 in Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein
